Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596

Roberto Contieri; Patrick J. Hensley; Ashish M. Kamat

doi:10.1016/j.euo.2023.09.018

Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596

Roberto Contieri, Patrick J. Hensley, Ashish M. Kamat

Urology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	301
Number of pages	1
Journal	European Urology Oncology
Volume	7
Issue number	2
DOIs	https://doi.org/10.1016/j.euo.2023.09.018
State	Published - Apr 1 2024

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.euo.2023.09.018

Cite this

Contieri, R., Hensley, P. J., & Kamat, A. M. (2024). Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. European Urology Oncology, 7(2), 301. https://doi.org/10.1016/j.euo.2023.09.018

Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. / Contieri, Roberto; Hensley, Patrick J.; Kamat, Ashish M.
In: European Urology Oncology, Vol. 7, No. 2, 01.04.2024, p. 301.

Research output: Contribution to journal › Letter › peer-review

Contieri, R, Hensley, PJ & Kamat, AM 2024, 'Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596', European Urology Oncology, vol. 7, no. 2, pp. 301. https://doi.org/10.1016/j.euo.2023.09.018

Contieri R, Hensley PJ, Kamat AM. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. European Urology Oncology. 2024 Apr 1;7(2):301. doi: 10.1016/j.euo.2023.09.018

Contieri, Roberto ; Hensley, Patrick J. ; Kamat, Ashish M. / Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re : Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. In: European Urology Oncology. 2024 ; Vol. 7, No. 2. pp. 301.

@article{bd55418a758a44ceadd57d9f46df1fbe,

title = "Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Gu{\'e}rin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596",

author = "Roberto Contieri and Hensley, {Patrick J.} and Kamat, {Ashish M.}",

year = "2024",

month = apr,

day = "1",

doi = "10.1016/j.euo.2023.09.018",

language = "English (US)",

volume = "7",

pages = "301",

journal = "European Urology Oncology",

issn = "2588-9311",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re

T2 - Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596

AU - Contieri, Roberto

AU - Hensley, Patrick J.

AU - Kamat, Ashish M.

PY - 2024/4/1

Y1 - 2024/4/1

UR - http://www.scopus.com/inward/record.url?scp=85188761119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85188761119&partnerID=8YFLogxK

U2 - 10.1016/j.euo.2023.09.018

DO - 10.1016/j.euo.2023.09.018

M3 - Letter

C2 - 37806840

AN - SCOPUS:85188761119

SN - 2588-9311

VL - 7

SP - 301

JO - European Urology Oncology

JF - European Urology Oncology

IS - 2

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this